MiR-203, a tumor suppressor frequently down-regulated by promoter hypermethylation in rhabdomyosarcoma

Journal of Biological Chemistry

Volumn 289, Issue 1, 2014, Pages 529-539

  Diao, Yarui ^a,b   Guo, Xing ^b   Jiang, Lei ^b   Wang, Gang ^b   Zhang, Chao ^a   Wan, Jun ^a   Jin, Yan ^c   Wu, Zhenguo ^a,b  

^a PEKING UNIVERSITY   (China)

^b HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYPERMETHYLATION; LEUKEMIA INHIBITORY FACTORS; MYOGENIC DIFFERENTIATIONS; RHABDOMYOSARCOMA; SOFT TISSUE SARCOMA; TUMOR SUPPRESSORS; TUMORIGENESIS; YOUNG ADULTS;

CELL CULTURE; MUSCLE; PROTEINS; RNA;

TUMORS;

JANUS KINASE 1; LEUKEMIA INHIBITORY FACTOR RECEPTOR; MICRORNA; MICRORNA 203; NOTCH RECEPTOR; PROTEIN P63; STAT1 PROTEIN; STAT3 PROTEIN; UNCLASSIFIED DRUG; DNA; JAK1 PROTEIN, HUMAN; MIRN203 MICRORNA, HUMAN; STAT1 PROTEIN, HUMAN; STAT3 PROTEIN, HUMAN; TP63 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA METHYLATION; HUMAN; HUMAN TISSUE; MALE; MIGRATION INHIBITION; MITOSIS INHIBITION; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RHABDOMYOSARCOMA; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; CLINICAL TRIAL; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL DIFFERENTIATION; CELL LINE, TUMOR; DNA METHYLATION; DNA, NEOPLASM; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; JANUS KINASE 1; MALE; MICE; MICE, NUDE; MICRORNAS; NEOPLASM PROTEINS; PROMOTER REGIONS, GENETIC; RECEPTORS, NOTCH; RECEPTORS, OSM-LIF; RHABDOMYOSARCOMA; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 84891695147     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.494716     Document Type: Article

References (87)

1. Dagher, R., and Helman, L. (1999) Rhabdomyosarcoma: an overview. Oncologist 4, 34-44 (Pubitemid 29102453)
2. Anderson, J., Gordon, A., Pritchard-Jones, K., and Shipley, J. (1999) Genes, chromosomes, and rhabdomyosarcoma. Genes Chromosomes Cancer 26, 275-285 (Pubitemid 29529572)
3. Andrassy, R. J., Wiener, E. S., Raney, R. B., Hays, D. M., Arndt, C. A., Lobe, T. E., Lawrence, W., Anderson, J. R., Qualman, S. J., and Crist, W. M. (1999) Progress in the surgical management of vaginal rhabdomyosarcoma: a 25-year review from the Intergroup Rhabdomyosarcoma Study Group. J. Pediatr. Surg. 34, 731-734
4. Arndt, C. A., and Crist, W. M. (1999) Common musculoskeletal tumors of childhood and adolescence. N. Engl. J. Med. 341, 342-352
5. Rubin, B. P., Nishijo, K., Chen, H. I., Yi, X., Schuetze, D. P., Pal, R., Prajapati, S. I., Abraham, J., Arenkiel, B. R., Chen, Q. R., Davis, S., McCleish, A. T., Capecchi, M. R., Michalek, J. E., Zarzabal, L. A., Khan, J., Yu, Z., Parham, D. M., Barr, F. G., Meltzer, P. S., Chen, Y., and Keller, C. (2011) Evidence for an unanticipated relationship between undifferentiated pleomorphic sarcoma and embryonal rhabdomyosarcoma. Cancer Cell 19, 177-191
6. Hettmer, S., and Wagers, A. J. (2010) Muscling in: Uncovering the origins of rhabdomyosarcoma. Nat. Med. 16, 171-173
7. Keller, C., Arenkiel, B. R., Coffin, C. M., El-Bardeesy, N., De Pinho, R. A., and Capecchi, M. R. (2004) Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function. Genes Dev. 18, 2614-2626 (Pubitemid 39453101)
8. Hatley, M. E., Tang, W., Garcia, M. R., Finkelstein, D., Millay, D. P., Liu, N., Graff, J., Galindo, R. L., and Olson, E. N. (2012) A mouse model of rhabdomyosarcoma originating from the adipocyte lineage. Cancer Cell 22, 536-546
9. Vogelstein, B., and Kinzler, K. W. (2004) Cancer genes and the pathways they control. Nat. Med. 10, 789-799 (Pubitemid 39070849)
10. Hanahan, D., and Weinberg, R. A. (2011) Hallmarks of cancer: the next generation. Cell 144, 646-674
11. Lee, R. C., Feinbaum, R. L., and Ambros, V. (1993) The C. elegans heterochronic heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75, 843-854 (Pubitemid 24014542)
12. Kozomara, A., and Griffiths-Jones, S. (2011) miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 39, D152-D157
13. Krol, J., Loedige, I., and Filipowicz, W. (2010) The widespread regulation of microRNA biogenesis, function and decay. Nat. Rev. Genet. 11, 597-610
14. Newman, M. A., and Hammond, S. M. (2010) Emerging paradigms of regulated microRNA processing. Genes Dev. 24, 1086-1092
15. Chekulaeva, M., and Filipowicz, W. (2009) Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells. Curr. Opin. Cell Biol. 21, 452-460
16. Siomi, H., and Siomi, M. C. (2010) Posttranscriptional regulation of microRNA biogenesis in animals. Mol. Cell 38, 323-332
17. Bartel, D. P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297
18. Bushati, N., and Cohen, S. M. (2007) microRNA functions. Annu. Rev. Cell Dev. Biol. 23, 175-205
19. Kloosterman, W. P., and Plasterk, R. H. (2006) The diverse functions of microRNAs in animal development and disease. Dev. Cell 11, 441-450 (Pubitemid 44430905)
20. Garzon, R., Calin, G. A., and Croce, C. M. (2009) MicroRNAs in cancer. Annu. Rev. Med. 60, 167-179
21. Croce, C. M. (2009) Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet. 10, 704-714
22. Di Leva, G., and Croce, C. M. (2010) Roles of small RNAs in tumor formation. Trends Mol. Med. 16, 257-267
23. Lujambio, A., and Lowe, S. W. (2012) The microcosmos of cancer. Nature 482, 347-355
24. Kasinski, A. L., and Slack, F. J. (2011) Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat. Rev. Cancer 11, 849-864
25. Rota, R., Ciarapica, R., Giordano, A., Miele, L., and Locatelli, F. (2011) MicroRNAs in rhabdomyosarcoma: pathogenetic implications and translational potentiality. Mol. Cancer 10, 120
26. Rao, P. K., Missiaglia, E., Shields, L., Hyde, G., Yuan, B., Shepherd, C. J., Shipley, J., and Lodish, H. F. (2010) Distinct roles for miR-1 and miR-133a in the proliferation and differentiation of rhabdomyosarcoma cells. FASEB J. 24, 3427-3437
27. Taulli, R., Bersani, F., Foglizzo, V., Linari, A., Vigna, E., Ladanyi, M., Tuschl, T., and Ponzetto, C. (2009) The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation. J. Clin. Invest. 119, 2366-2378
28. Yan, D., Dong Xda, E., Chen, X., Wang, L., Lu, C., Wang, J., Qu, J., and Tu, L. (2009) MicroRNA-1/206 targets c-Met and inhibits rhabdomyosarcoma development. J. Biol. Chem. 284, 29596-29604
29. Williams, A. H., Liu, N., Van Rooij, E., and Olson, E. N. (2009) MicroRNA control of muscle development and disease. Curr. Opin. Cell Biol. 21, 461-469
30. Wang, H., Garzon, R., Sun, H., Ladner, K. J., Singh, R., Dahlman, J., Cheng, A., Hall, B. M., Qualman, S. J., Chandler, D. S., Croce, C. M., and Guttridge, D. C. (2008) NF-'B-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell 14, 369-381
31. Ciarapica, R., Russo, G., Verginelli, F., Raimondi, L., Donfrancesco, A., Rota, R., and Giordano, A. (2009) Deregulated expression of miR-26a and Ezh2 in rhabdomyosarcoma. Cell Cycle 8, 172-175
32. Sarver, A. L., Li, L., and Subramanian, S. (2010) MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration. Cancer Res. 70, 9570-9580
33. Bueno, M. J., Pérez De Castro, I., Gómez De Cedrón, M., Santos, J., Calin, G. A., Cigudosa, J. C., Croce, C. M., Fernández-Piqueras, J., and Malumbres, M. (2008) Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell 13, 496-506 (Pubitemid 351763902)
34. Kozaki, K., Imoto, I., Mogi, S., Omura, K., and Inazawa, J. (2008) Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res. 68, 2094-2105 (Pubitemid 351521781)
35. Craig, V. J., Cogliatti, S. B., Rehrauer, H., Wündisch, T., and Müller, A. (2011) Epigenetic silencing of microRNA-203 dysregulates ABL1 expression and drives Helicobacter-associated gastric lymphomagenesis. Cancer Res. 71, 3616-3624
36. Furuta, M., Kozaki, K. I., Tanaka, S., Arii, S., Imoto, I., and Inazawa, J. (2010) miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 31, 766-776
37. Viticchiè, G., Lena, A. M., Latina, A., Formosa, A., Gregersen, L. H., Lund, A. H., Bernardini, S., Mauriello, A., Miano, R., Spagnoli, L. G., Knight, R. A., Candi, E., and Melino, G. (2011) MiR-203 controls proliferation, migration, and invasive potential of prostate cancer cell lines. Cell Cycle 10, 1121-1131
38. Boll, K., Reiche, K., Kasack, K., Mörbt, N., Kretzschmar, A. K., Tomm, J. M., Verhaegh, G., Schalken, J., Von Bergen, M., Horn, F., and Hackermüller, J. (2013) miR-130a, miR-203, and miR-205 jointly repress key oncogenic pathways and are downregulated in prostate carcinoma. Oncogene 32, 277-285
39. Yanaihara, N., Caplen, N., Bowman, E., Seike, M., Kumamoto, K., Yi, M., Stephens, R. M., Okamoto, A., Yokota, J., Tanaka, T., Calin, G. A., Liu, C. G., Croce, C. M., and Harris, C. C. (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9, 189-198 (Pubitemid 43357945)
40. Schetter, A. J., Leung, S. Y., Sohn, J. J., Zanetti, K. A., Bowman, E. D., Yanaihara, N., Yuen, S. T., Chan, T. L., Kwong, D. L., Au, G. K., Liu, C. G., Calin, G. A., Croce, C. M., and Harris, C. C. (2008) MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299, 425-436 (Pubitemid 351185951)
41. Greither, T., Grochola, L. F., Udelnow, A., Lautenschläger, C., Würl, P., and Taubert, H. (2010) Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival. Int. J. Cancer 126, 73-80
42. Iorio, M. V., Visone, R., Di Leva, G., Donati, V., Petrocca, F., Casalini, P., Taccioli, C., Volinia, S., Liu, C. G., Alder, H., Calin, G. A., Ménard, S., and Croce, C. M. (2007) MicroRNA signatures in human ovarian cancer. Cancer Res. 67, 8699-8707 (Pubitemid 47437445)
43. Diao, Y., Wang, X., and Wu, Z. (2009) SOCS1, SOCS3, and PIAS1 promote myogenic differentiation by inhibiting the leukemia inhibitory factor-induced JAK1/STAT1/STAT3 pathway. Mol. Cell. Biol. 29, 5084-5093
44. Frommer, M., McDonald, L. E., Millar, D. S., Collis, C. M., Watt, F., Grigg, G. W., Molloy, P. L., and Paul, C. L. (1992) Agenomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc. Natl. Acad. Sci. U. S. A. 89, 1827-1831
45. Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., and Baylin, S. B. (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. U. S. A. 93, 9821-9826 (Pubitemid 26296693)
46. Kantlehner, M., Kirchner, R., Hartmann, P., Ellwart, J. W., Alunni-Fabbroni, M., and Schumacher, A. (2011) A high-throughput DNA methylation analysis of a single cell. Nucleic Acids Res. 39, e44
47. Diao, Y., Guo, X., Li, Y., Sun, K., Lu, L., Jiang, L., Fu, X., Zhu, H., Sun, H., Wang, H., and Wu, Z. (2012) Pax3/7BP is a Pax7- and Pax3-binding protein that regulates the proliferation of muscle precursor cells by an epigenetic mechanism. Cell Stem Cell 11, 231-241
48. Tapscott, S. J., Thayer, M. J., and Weintraub, H. (1993) Deficiency in rhabdomyosarcomas of a factor required for MyoD activity and myogenesis. Science 259, 1450-1453 (Pubitemid 23101380)
49. Lena, A. M., Shalom-Feuerstein, R., Rivetti Di Val Cervo, P., Aberdam, D., Knight, R. A., Melino, G., and Candi, E. (2008) miR-203 represses 'stemness' by repressing Np63. Cell Death Differ. 15, 1187-1195 (Pubitemid 351850972)
50. Yi, R., Poy, M. N., Stoffel, M., and Fuchs, E. (2008) A skin microRNA promotes differentiation by repressing 'stemness'. Nature 452, 225-229 (Pubitemid 351380241)
51. Graziano, V., and De Laurenzi, V. (2011) Role of p63 in cancer development. Biochim. Biophys. Acta 1816, 57-66
52. Sasaki, Y., Ishida, S., Morimoto, I., Yamashita, T., Kojima, T., Kihara, C., Tanaka, T., Imai, K., Nakamura, Y., and Tokino, T. (2002) The p53 family member genes are involved in the Notch signal pathway. J. Biol. Chem. 277, 719-724 (Pubitemid 34952112)
53. Ma, J., Meng, Y., Kwiatkowski, D. J., Chen, X., Peng, H., Sun, Q., Zha, X., Wang, F., Wang, Y., Jing, Y., Zhang, S., Chen, R., Wang, L., Wu, E., Cai, G., Malinowska-Kolodziej, I., Liao, Q., Liu, Y., Zhao, Y., Sun, Q., Xu, K., Dai, J., Han, J., Wu, L., Zhao, R. C., Shen, H., and Zhang, H. (2010) Mammalian target of rapamycin regulates murine and human cell differentiation through STAT3/p63/Jagged/Notch cascade. J. Clin. Invest. 120, 103-114
54. Kopan, R., and Ilagan, M. X. (2009) The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 137, 216-233
55. Kopan, R., Nye, J. S., and Weintraub, H. (1994) The intracellular domain of mouse Notch: a constitutively activated repressor of myogenesis directed at the basic helix-loop-helix region of MyoD. Development 120, 2385-2396 (Pubitemid 24268814)
56. Shawber, C., Nofziger, D., Hsieh, J. J., Lindsell, C., Bögler, O., Hayward, D., and Weinmaster, G. (1996) Notch signaling inhibits muscle cell differentiation through a CBF1-independent pathway. Development 122, 3765-3773 (Pubitemid 27033873)
57. Wilson-Rawls, J., Molkentin, J. D., Black, B. L., and Olson, E. N. (1999) Activated notch inhibits myogenic activity of the MADS-Box transcription factor myocyte enhancer factor 2C. Mol. Cell. Biol. 19, 2853-2862 (Pubitemid 29144529)
58. Kuroda, K., Tani, S., Tamura, K., Minoguchi, S., Kurooka, H., and Honjo, T. (1999) Delta-induced Notch signaling mediated by RBP-J inhibits MyoD expression and myogenesis. J. Biol. Chem. 274, 7238-7244
59. Shearman, M. S., Beher, D., Clarke, E. E., Lewis, H. D., Harrison, T., Hunt, P., Nadin, A., Smith, A. L., Stevenson, G., and Castro, J. L. (2000) L-685, 458, an aspartyl protease transition state mimic, is a potent inhibitor of amyloid β-protein precursor γ-secretase activity. Biochemistry 39, 8698-8704 (Pubitemid 30602778)
60. Lewis, B. P., Shih, I. H., Jones-Rhoades, M. W., Bartel, D. P., and Burge, C. B. (2003) Prediction of mammalian microRNA targets. Cell 115, 787-798 (Pubitemid 38058492)
61. John, B., Enright, A. J., Aravin, A., Tuschl, T., Sander, C., and Marks, D. S. (2004) Human microRNA targets. PLoS Biol. 2, e363
62. Heinrich, P. C., Behrmann, I., Haan, S., Hermanns, H. M., Müller-Newen, G., and Schaper, F. (2003) Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 374, 1-20 (Pubitemid 37046923)
63. Jones, S. A., Scheller, J., and Rose-John, S. (2011) Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling. J. Clin. Invest. 121, 3375-3383
64. Müller-Newen, G. (2003) The cytokine receptor gp130: faithfully promiscuous. Sci. STKE 2003, PE40
65. Sun, L., Ma, K., Wang, H., Xiao, F., Gao, Y., Zhang, W., Wang, K., Gao, X., Ip, N., and Wu, Z. (2007) JAK1-STAT1-STAT3, a key pathway promoting proliferation and preventing premature differentiation of myoblasts. J. Cell Biol. 179, 129-138 (Pubitemid 47606689)
66. Xiao, F., Wang, H., Fu, X., Li, Y., Ma, K., Sun, L., Gao, X., and Wu, Z. (2011) Oncostatin M inhibits myoblast differentiation and regulates muscle regeneration. Cell Res. 21, 350-364
67. Missiaglia, E., Shepherd, C. J., Patel, S., Thway, K., Pierron, G., Pritchard-Jones, K., Renard, M., Sciot, R., Rao, P., Oberlin, O., Delattre, O., and Shipley, J. (2010) MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas. Br. J. Cancer 102, 1769-1777
68. Noguchi, S., Mori, T., Otsuka, Y., Yamada, N., Yasui, Y., Iwasaki, J., Kumazaki, M., Maruo, K., and Akao, Y. (2012) Anti-oncogenic microRNA-203 induces senescence by targeting E2F3 protein in human melanoma cells. J. Biol. Chem. 287, 11769-11777
69. Dotto, G. P. (2009) Crosstalk of Notch with p53 and p63 in cancer growth control. Nat. Rev. Cancer 9, 587-595
70. Sang, L., Coller, H. A., and Roberts, J. M. (2008) Control of the reversibility of cellular quiescence by the transcriptional repressor HES1. Science 321, 1095-1100
71. Wysoczynski, M., Miekus, K., Jankowski, K., Wanzeck, J., Bertolone, S., Janowska-Wieczorek, A., Ratajczak, J., and Ratajczak, M. Z. (2007) Leukemia inhibitory factor: a newly identified metastatic factor in rhabdomyosarcomas. Cancer Res. 67, 2131-2140 (Pubitemid 46424232)
72. Wang, Z. Y., and Chen, Z. (2008) Acute promyelocytic leukemia: from highly fatal to highly curable. Blood 111, 2505-2515
73. Mishra, P. J., and Merlino, G. (2009) MicroRNA reexpression as differentiation therapy in cancer. J. Clin. Invest. 119, 2119-2123
74. Conboy, I. M., and Rando, T. A. (2002) The regulation of Notch signaling controls satellite cell activation and cell fate determination in postnatal myogenesis. Dev. Cell 3, 397-409
75. Schuster-Gossler, K., Cordes, R., and Gossler, A. (2007) Premature myogenic differentiation and depletion of progenitor cells cause severe muscle hypotrophy in Delta1 mutants. Proc. Natl. Acad. Sci. U. S. A. 104, 537-542 (Pubitemid 46123060)
76. Vasyutina, E., Lenhard, D. C., and Birchmeier, C. (2007) Notch function in myogenesis. Cell Cycle 6, 1451-1454
77. Vasyutina, E., Lenhard, D. C., Wende, H., Erdmann, B., Epstein, J. A., and Birchmeier, C. (2007) RBP-J (Rbpsuh) is essential to maintain muscle progenitor cells and to generate satellite cells. Proc. Natl. Acad. Sci. U. S. A. 104, 4443-4448 (Pubitemid 47186245)
78. Mourikis, P., Gopalakrishnan, S., Sambasivan, R., and Tajbakhsh, S. (2012) Cell-autonomous Notch activity maintains the temporal specification potential of skeletal muscle stem cells. Development 139, 4536-4548
79. Mourikis, P., Sambasivan, R., Castel, D., Rocheteau, P., Bizzarro, V., and Tajbakhsh, S. (2012) A critical requirement for notch signaling in maintenance of the quiescent skeletal muscle stem cell state. Stem Cells 30, 243-252
80. Bjornson, C. R., Cheung, T. H., Liu, L., Tripathi, P. V., Steeper, K. M., and Rando, T. A. (2012) Notch signaling is necessary to maintain quiescence in adult muscle stem cells. Stem Cells 30, 232-242
81. Lepper, C., Low, S., and Partridge, T. A. (2012) The satellite cell builds its nest under Notch's guidance. Cell Stem Cell 11, 443-444
82. Bröhl, D., Vasyutina, E., Czajkowski, M. T., Griger, J., Rassek, C., Rahn, H. P., Purfürst, B., Wende, H., and Birchmeier, C. (2012) Colonization of the satellite cell niche by skeletal muscle progenitor cells depends on Notch signals. Dev. Cell 23, 469-481
83. Kong, Y. W., Ferland-McCollough, D., Jackson, T. J., and Bushell, M. (2012) microRNAs in cancer management. Lancet Oncol. 13, e249-258
84. Janssen, H. L., Reesink, H. W., Lawitz, E. J., Zeuzem, S., Rodriguez-Torres, M., Patel, K., Van Der Meer, A. J., Patick, A. K., Chen, A., Zhou, Y., Persson, R., King, B. D., Kauppinen, S., Levin, A. A., and Hodges, M. R. (2013) Treatment of HCV infection by targeting microRNA. N. Engl. J. Med. 368, 1685-1694
85. Tsai, H. C., Li, H., Van Neste, L., Cai, Y., Robert, C., Rassool, F. V., Shin, J. J., Harbom, K. M., Beaty, R., Pappou, E., Harris, J., Yen, R. W., Ahuja, N., Brock, M. V., Stearns, V., Feller-Kopman, D., Yarmus, L. B., Lin, Y. C., Welm, A. L., Issa, J. P., Minn, I., Matsui, W., Jang, Y. Y., Sharkis, S. J., Baylin, S. B., and Zahnow, C. A. (2012) Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells. Cancer Cell 21, 430-446
86. Baylin, S. B., and Jones, P. A. (2011) A decade of exploring the cancer epigenome-biological and translational implications. Nat. Rev. Cancer 11, 726-734
87. Ecke, I., Petry, F., Rosenberger, A., Tauber, S., Mönkemeyer, S., Hess, I., Dullin, C., Kimmina, S., Pirngruber, J., Johnsen, S. A., Uhmann, A., Nitzki, F., Wojnowski, L., Schulz-Schaeffer, W., Witt, O., and Hahn, H. (2009) Antitumor effects of a combined 5-aza-2'deoxycytidine and valproic acid treatment on rhabdomyosarcoma and medulloblastoma in Ptch mutant mice. Cancer Res. 69, 887-895